# Hospital Universitario La Paz: Observational study in Hepatocellular Carcinoma (HCC) (417 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Hospital Universitario La Paz |
| Sponsor type | Academic and hospital |
| Study | Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort. |
| NCT ID | NCT07872319 |
| Phase | Observational |
| Status | completed |
| Conditions | Hepatocellular Carcinoma (HCC) |
| Target enrollment | 417 |
| Site countries | Spain |
| Posted | 2026-10-13 |
| Planned start | 2022-02-02 |
| Event | Newly registered study |
| Event date | 2026-10-13 |

## Why this score
- 417 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07872319). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.